rs761846391

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The ENST00000377211.8(EDNRB):​c.164T>G​(p.Leu55Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,612,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

EDNRB
ENST00000377211.8 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.38

Publications

0 publications found
Variant links:
Genes affected
EDNRB (HGNC:3180): (endothelin receptor type B) The protein encoded by this gene is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Studies suggest that the multigenic disorder, Hirschsprung disease type 2, is due to mutations in the endothelin receptor type B gene. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
OBI1-AS1 (HGNC:42700): (OBI1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037023604).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000138 (21/152198) while in subpopulation AFR AF = 0.000506 (21/41514). AF 95% confidence interval is 0.000338. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EDNRBNM_001201397.2 linkc.164T>G p.Leu55Arg missense_variant Exon 1 of 8 NP_001188326.1 P24530-3A0A024R638
EDNRBNM_000115.5 linkc.-51-828T>G intron_variant Intron 1 of 7 NP_000106.1 P24530-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EDNRBENST00000377211.8 linkc.164T>G p.Leu55Arg missense_variant Exon 1 of 8 1 ENSP00000366416.4 P24530-3
EDNRBENST00000643890.1 linkc.-107T>G 5_prime_UTR_variant Exon 1 of 7 ENSP00000495815.1 A0A2R8Y748
EDNRBENST00000646948.1 linkc.-51-828T>G intron_variant Intron 1 of 7 ENSP00000493895.1 P24530-1

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152080
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000414
AC:
10
AN:
241410
AF XY:
0.0000302
show subpopulations
Gnomad AFR exome
AF:
0.000420
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1460424
Hom.:
0
Cov.:
30
AF XY:
0.0000151
AC XY:
11
AN XY:
726482
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33476
American (AMR)
AF:
0.000112
AC:
5
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52270
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111738
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41514
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000132
Hom.:
0
Bravo
AF:
0.000151
ExAC
AF:
0.0000259
AC:
3
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 05, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The p.Leu55Arg vari ant in EDNRB has not been previously reported in individuals with hearing loss. This variant has been identified in 2/8470 African chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs761846391). Al though this variant has been seen in the general population, its frequency is no t high enough to rule out a pathogenic role. The Leucine (Leu) at position 55 is not conserved in mammals or evolutionary distant species, raising the possibili ty that a change at this position may be tolerated. Additional computational pre diction tools suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, whil e the clinical significance of the p.Leu55Arg variant is uncertain, these data s uggest that it is more likely to be benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.17
DANN
Benign
0.95
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.037
T
MetaSVM
Benign
-0.92
T
PhyloP100
-1.4
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.030
N
REVEL
Benign
0.088
Sift
Benign
0.26
T
Polyphen
0.037
B
Vest4
0.057
MVP
0.23
MPC
0.67
ClinPred
0.070
T
GERP RS
-4.2
PromoterAI
-0.12
Neutral
gMVP
0.071
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761846391; hg19: chr13-78493587; API